Skip to content
Insider tapeFilings through Fri, Oct 2
Watchlist

Michael David Garrison

Evp & Pres Med.Essntl&Biopharm at Becton Dickinson & Co (BDX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $784K

Reported trades

Filed Stock Type Shares Price Value Since
Jun 25SEC BDXBecton Dickinson & Co Sell Plan 1,100 $145.66 $160K +24.0%
Jun 11SEC BDXBecton Dickinson & Co Sell Plan 1,100 $151.48 $167K +19.3%
Jan 16SEC BDXBecton Dickinson & Co Sell Plan 600 $209.00 $125K -13.6%
Jan 16SEC BDXBecton Dickinson & Co Sell Plan 1,010 $206.54 $209K -12.5%
Dec 17SEC BDXBecton Dickinson & Co Sell Plan 629 $196.03 $123K -7.8%
  • Sell

    Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $160K of BDX at $145.66 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $167K of BDX at $151.48 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $125K of BDX at $209.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $209K of BDX at $206.54 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $123K of BDX at $196.03 — pre-scheduled 10b5-1 plan sale.